IBA signs contract with partner CGN Medical Technology for the installation of a ProteusPLUS system in China - Seite 2

HU Dongming, Chairman of CGN Nuclear Technology Development Co., Ltd., added: “We were happy to welcome Mr. Legrain and his team to CGN in Shenzhen and celebrate the fantastic progress we have made in the delivery of this innovative technology to the Chinese market. We are pleased and honored to be working with the West China International Cancer Treatment Center which demonstrates the potential of our collaboration for the benefit of cancer patients in China. We look forward to strengthening our relationship with IBA as we continue with this project.”

                                              

***ENDS***
 [1] ProteusPLUS is a brand name of Proteus235

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA is also a leading player in the fields of industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 1,800 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com

About CGNNT

CGNNT (stock code: 000881.SZ) is a leading company in the nuclear technology application industry that was restructured and listed in Shenzhen Stock Exchange on February 27, 2017, after the major asset restructuring of CGN Nuclear Technology Application Co., Ltd. and China Dalian International Cobusiness (Group) Holdings Ltd. Up to now, CGNNT has completed the layout of core business units such as accelerator manufacturing, application development and technical service and modified polymer material. Their market share leads the nation. CGNNT mainly incubates such emerging services as radiation detection and security inspection (managed) and new irradiation application, and actively expands to high-end fields such as nuclear medicine (especially PT field), nuclear agricultural science and nuclear environmental protection, with market size firmly ahead in China.